The differential expression of PSGL-1 during myeloid hematopoietic development and the quantification of PSGL-1 can be employed as a marker of the immunophenotype of AML subpopulations, with greater expression observed in myeloid cells and less in monoblasts [94]. This evidence concerns the gene SELPLG and acute myeloid leukemia.